These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17305906)

  • 1. Sézary syndrome treated with narrowband ultraviolet B: time-course measurement of serum levels of CCL17/CCL27.
    Masui Y; Sugaya M; Kagami S; Fujita H; Yano S; Nagao M; Komine M; Saeki H; Ihn H; Kikuchi K; Tamaki K
    Clin Exp Dermatol; 2007 Jan; 32(1):57-9. PubMed ID: 17305906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
    Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
    Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Correlation of Serums CCL11, CCL17, CCL26, and CCL27 and Disease Severity in Patients with Urticaria.
    Lu T; Jiao X; Si M; He P; Zou J; Zhang S; Zeng K
    Dis Markers; 2016; 2016():1381760. PubMed ID: 27057079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides.
    Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y
    J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
    Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
    Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
    Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
    Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of cutaneous T-cell lymphoma migration to the skin.
    Hoeller C; Richardson SK; Ng LG; Valero T; Wysocka M; Rook AH; Weninger W
    Cancer Res; 2009 Apr; 69(7):2704-8. PubMed ID: 19318575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
    Tapia B; Morel E; Martín-Díaz MA; Díaz R; Alves-Ferreira J; Rubio P; Padial A; Bellón T
    Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR4 and CCR10 are expressed on epidermal keratinocytes and are involved in cutaneous immune reaction.
    Fujimoto S; Uratsuji H; Saeki H; Kagami S; Tsunemi Y; Komine M; Tamaki K
    Cytokine; 2008 Oct; 44(1):172-8. PubMed ID: 18782672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of CCL17/TARC in various skin diseases.
    Tamaki K; Kakinuma T; Saeki H; Horikawa T; Kataoka Y; Fujisawa T; Sato S; Takehara K; Nakahara T; Fukagawa S; Furue M
    J Dermatol; 2006 Apr; 33(4):300-2. PubMed ID: 16674799
    [No Abstract]   [Full Text] [Related]  

  • 11. CXCL13 is highly produced by Sézary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines.
    Picchio MC; Scala E; Pomponi D; Caprini E; Frontani M; Angelucci I; Mangoni A; Lazzeri C; Perez M; Remotti D; Bonoldi E; Benucci R; Baliva G; Lombardo GA; Napolitano M; Russo G; Narducci MG
    Cancer Res; 2008 Sep; 68(17):7137-46. PubMed ID: 18757429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
    Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
    Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cytokine and chemokine profiles in patients with alopecia areata.
    Bilgic O; Sivrikaya A; Unlu A; Altinyazar HC
    J Dermatolog Treat; 2016; 27(3):260-3. PubMed ID: 26367497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
    Niens M; Visser L; Nolte IM; van der Steege G; Diepstra A; Cordano P; Jarrett RF; Te Meerman GJ; Poppema S; van den Berg A
    Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severity.
    Oflazoglu E; Simpson EL; Takiguchi R; Grewal IS; Hanifin JM; Gerber HP
    Eur J Dermatol; 2008; 18(1):41-9. PubMed ID: 18086588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL18 is expressed in patients with bullous pemphigoid and parallels disease course.
    Günther C; Carballido-Perrig N; Kopp T; Carballido JM; Pfeiffer C
    Br J Dermatol; 2009 Apr; 160(4):747-55. PubMed ID: 19120345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peripheral blood Sézary cells and the diagnosis of Sézary syndrome].
    Tessier-Marteau A; Le Corre Y; Gérard J; Avenel-Audran M; Geneviève F; Verret JL; Zandecki M
    Ann Biol Clin (Paris); 2008; 66(4):447-53. PubMed ID: 18725348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for TARC/CCL17, a CC chemokine, in New Zealand mice.
    Okamoto H; Nishimura H; Kamatani N
    Rheumatology (Oxford); 2005 Jun; 44(6):819-20. PubMed ID: 15741195
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of T helper 2 chemokine production by narrowband ultraviolet B in cultured keratinocytes.
    Hino R; Kobayashi M; Mori T; Orimo H; Shimauchi T; Kabashima K; Tokura Y
    Br J Dermatol; 2007 May; 156(5):830-7. PubMed ID: 17313491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.